Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $2.8 million.

  • Treace Medical Concepts' Depreciation & Amortization (CF) rose 2879.0% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year increase of 2642.43%. This contributed to the annual value of $8.4 million for FY2024, which is 5730.57% up from last year.
  • As of Q3 2025, Treace Medical Concepts' Depreciation & Amortization (CF) stood at $2.8 million, which was up 2879.0% from $2.6 million recorded in Q2 2025.
  • Over the past 5 years, Treace Medical Concepts' Depreciation & Amortization (CF) peaked at $2.8 million during Q3 2025, and registered a low of $100000.0 during Q2 2021.
  • In the last 5 years, Treace Medical Concepts' Depreciation & Amortization (CF) had a median value of $1.1 million in 2023 and averaged $1.3 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first plummeted by 7500.0% in 2021, then surged by 30000.0% in 2022.
  • Over the past 5 years, Treace Medical Concepts' Depreciation & Amortization (CF) (Quarter) stood at $276000.0 in 2021, then skyrocketed by 232.25% to $917000.0 in 2022, then skyrocketed by 92.91% to $1.8 million in 2023, then grew by 26.46% to $2.2 million in 2024, then rose by 24.18% to $2.8 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $2.8 million for Q3 2025, versus $2.6 million for Q2 2025 and $2.5 million for Q1 2025.